Study of infection and body chemicals in dialysis patients with sepsis
Part of Infections clinical trials.
This study looks at germs and body chemicals in dialysis patients who are in the hospital with sepsis. The goal is to learn more about how these factors affect recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are on hemodialysis (a type of dialysis using a machine).
- You are currently in the hospital with sepsis (a serious infection affecting the whole body).
- You are able to give written permission (informed consent) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study follows adults hospitalized with sepsis to help improve care. You will be visited daily while in the hospital and get a phone call after you leave.
This trial tests whether a newer, higher-performing dialysis filter helps people with kidney failure and sepsis better than the standard filter. It focuses on patients with high levels of inflammation (measured by a marker called interleukin-6).
This study looks at different types (“endotypes”) of sepsis in adults to better understand what’s happening in the body and how patients may respond. You might be asked to provide information and samples as the study tries to sort sepsis into meaningful subgroups.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.